AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...
AstraZeneca chief Pascal Soriot has said a deepening criminal probe into his company’s Chinese business is being taken “very ...
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning to those joining from the U.S., good afternoon to ...
AstraZeneca and Daiichi Sankyo have submitted a new Biologics License Application (BLA) for accelerated approval in the US ...
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the ...
GlobalData on MSN6d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialA Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...
The jobs include roles in engineering and technical services and global supply chain functions. Read more at straitstimes.com ...
The pharmaceutical giant raised its full-year guidance after third-quarter revenue and core earnings per share topped ...
The pharma giant confirmed that Wang Lei, the executive vice president who oversaw AstraZeneca’s rapid expansion in China, is ...
AstraZeneca's investment in South African trials has more ... that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback